Established in 1992, the Department of Respiratory and Critical Care Medicine (Pulmonology) at Shenzhen Traditional Chinese Medicine (TCM) Hospital is a comprehensive clinical department that integrates medical care, education, and research. Guided by the hospital’s motto "Unity, Integrity, Inheritance, Innovation", we adhere to a development philosophy that prioritizes equal emphasis on TCM and Western medicine, highlights TCM’s unique strengths, integrates internal and external therapies, and combines treatment with prevention. Through years of dedicated discipline development, we have evolved into a leading respiratory care center with robust technical expertise, distinctive TCM features, proven clinical outcomes, and state-of-the-art diagnostic and treatment equipment.
Department Honors
Key TCM Specialty of Guangdong Province
Key TCM Specialty of Shenzhen
National Standardized Construction Unit of Pulmonary and Critical Care Medicine (PCCM) for Tertiary Hospitals
National PCCM Respiratory Rehabilitation Training Base
Chairman Unit of the Pulmonary Disease Committee, Shenzhen Association of TCM
Training Base for Integrated TCM-Western Medicine Pulmonary Rehabilitation, Guangdong Medical Association for Primary Healthcare
Quality Control Center for TCM Internal Medicine, Shenzhen
Expert Team
Our department boasts an exceptional team of medical professionals, including:
1 Provincial-level Famous TCM Physician
1 Municipal-level Famous TCM Physician
3 Provincial/Municipal-level Inheritance Mentors for Famous TCM Physicians
3 Doctoral Supervisors
6 Master’s Supervisors
Many team members have earned prestigious titles such as "Shenzhen Outstanding Physician," "Anti-Epidemic Hero," "Outstanding TCM Talent of the Pengcheng Qihuang Program," and "Shenzhen Health Elite Talent."
Academic Leader
Vice President Chen Sheng is a distinguished Pengcheng Xinglin Leading Talent and the sole "Xinglin Famous Physician" from Guangzhou University of Chinese Medicine based in Shenzhen. He serves as:
Head of the Shenzhen TCM Expert Group for COVID-19 Prevention and Treatment
Vice President of the Respiratory Branch, World Federation of Chinese Medicine Societies
Vice Chairman of the Respiratory Branch, Guangdong Pharmaceutical Association
Department Leadership
The department has been steered by three successive chief physicians: Gao Xue, Qu Jinglai, and Chen Sheng, whose contributions laid a solid foundation for its growth. Since 2023, Chief Physician Xie Wei has served as the department director, driving continuous innovation and development.
Clinical Services
We offer integrated TCM-Western medicine diagnosis, treatment, research, and education for a wide range of respiratory conditions, including:
Lung cancer and pulmonary nodules
Chronic obstructive pulmonary disease (COPD)
Bronchial asthma
Pulmonary interstitial fibrosis
Pneumonia
Bronchiectasis
Chronic bronchitis
Sleep apnea syndrome
We operate specialized clinics for pulmonary nodules/lung cancer, COPD, asthma, sleep-disordered breathing, and smoking cessation to provide targeted care.
Facilities & Operations
Inpatient Wards: 2 wards with 66 beds
Team: Over 40 medical professionals
Specialized Centers & Laboratories: Respiratory Endoscopy Center, Pulmonary Function Lab, TCM Comprehensive Therapy Room
Advanced Equipment: Electronic bronchoscopes, endobronchial ultrasound (EBUS), and other cutting-edge diagnostic tools
Volume: Annually, we serve over 80,000 outpatients and admit more than 1,800 inpatients
Academic Collaboration & Innovation
Through the "Famous Doctors, Top Hospitals, Elite Clinics" initiative, we maintain in-depth partnerships with the China-Japan Friendship Hospital (National Center for Integrated TCM-Western Medicine Respiratory Care). We have established inheritance studios for:
National TCM Master Chao Enxiang
Longjiang TCM School
National Famous TCM Physician Zhang Hongchun
Long-term guidance from national-level TCM experts and scholars helps us continuously elevate clinical capabilities, research innovation, and technology translation.
Epidemic Response & TCM Drug Development
We take a leading role in TCM-based prevention and treatment of respiratory infectious diseases. Our team led the formulation and ongoing optimization of the Shenzhen TCM Protocol for COVID-19 Prevention and Treatment, and developed an innovative TCM drug, Guben Qingfei Granules, which has received acceptance from the National Medical Products Administration (NMPA).
Smart Healthcare & Pulmonary Rehabilitation
We integrate TCM with modern technology to deliver full-cycle pulmonary rehabilitation via an intelligent data platform. We are also actively developing smart wards using wearable devices to enhance patient care.
TCM Dominant Therapies & Customized Medications
We focus on three core TCM strengths: managing cough, asthma, and dyspnea. Our clinical services extend to three emerging areas:
Precision diagnosis, treatment, and whole-cycle management of pulmonary nodules and lung cancer (integrated TCM-Western medicine)
Full-cycle pulmonary rehabilitation with integrated TCM-Western medicine
Interventional diagnosis and treatment via respiratory endoscopy
We provide patients with "precision, minimally invasive, full-cycle" care, supported by:
In-hospital preparations and approved formulas: Zhike Liyan Granules, Jiawei Chuanbei Pipa Syrup, Fuzheng Sanjie Pills, Huatan Pills, Feixian Pills
Customized TCM ointments: Yifei Bushen Ointment (lung and kidney tonifying), Jianpi Huatan Ointment (spleen-invigorating and phlegm-resolving), Huatan Dingzhi Ointment (smoking cessation)
TCM characteristic therapies: Autologous blood therapy, TCM nasal irrigation, bianstone moxibustion, auricular point pressing, etc.
Research Achievements
Over the past 5 years, we have:
Secured 3 projects from the National Natural Science Foundation of China, along with multiple provincial and ministerial-level research grants
Participated in 3 National Key R&D Programs
Received over 10 million yuan in research funding
Won awards such as the Science and Technology Award of the Chinese Society of TCM
Published more than 100 academic papers, including over 10 indexed in SCI journals
Compiled over 10 medical monographs
Filed 4 patents
